| Literature DB >> 28451358 |
Jessica A Kretzmann1,2, Diwei Ho1, Cameron W Evans1, Janice H C Plani-Lam2, Benjamin Garcia-Bloj2, A Elaaf Mohamed3, Megan L O'Mara3, Ethan Ford1,2,4, Dennis E K Tan1,2,4, Ryan Lister1,2,4, Pilar Blancafort2,5, Marck Norret1, K Swaminathan Iyer1.
Abstract
Tools for editing the genome and epigenome have revolutionised the field of molecular biology and represent a new frontier in targeted therapeutic intervention. Although efficiencies and specificities of genome editing technologies have improved with the development of TALEs and CRISPR platforms, intracellular delivery of these larger constructs still remains a challenge using existing delivery agents. Viral vectors, including lentiviruses and adeno-associated viruses, as well as some non-viral strategies, such as cationicEntities:
Year: 2017 PMID: 28451358 PMCID: PMC5376716 DOI: 10.1039/c7sc00097a
Source DB: PubMed Journal: Chem Sci ISSN: 2041-6520 Impact factor: 9.825
Fig. 1Polymer design and transfection efficiency in MCF-7 cells. (a) Synthesis of systematic dendronised polymer design and architecture; polymers are random statistical copolymers of HEMA and GMA where x = mol% GMA. Poly(amido amine) dendrons of different generation are clicked onto the linear polymer backbone. Reaction conditions: (i) NaN3, NH4Cl, DMF, 60 °C, 72 h; (ii) PMDETA, CuBr, DMF, r.t., 72 h; (iii) ethylenediamine, MeOH, 0 °C. (b and c) Representations of polymers prepared in this work. Schematics demonstrate how flexibility is systematically altered by varying dendron generation and dendron density independently. (d) Transfection efficiency of polymers delivering EGFP-encoding plasmid to MCF-7 cells at an N/P ratio of 10. Polymer 10c (x = 0.17, G5 PAMAM dendron) significantly outperformed traditional G5 PAMAM dendrimer (p ≤ 0.0001).
Fig. 2Transfection efficiency in MCF-7 cells comparing the effect of perfluoroalkyl modification of polymers on both small and large plasmids. (a and b) Fluorination of dendronised polymers increased EGFP-encoding pDNA transfection efficiency significantly in all cases ((a) p ≤ 0.0001; (b) p ≤ 0.001) and fluorinated dendronised polymers 11c and 12c achieved transfection efficiencies similar to Lipofectamine 2000 (p > 0.05). In (a), G4 and G5 PAMAM dendrons (9c, 10c, 11c and 12c) are compared, and in (b), G5 PAMAM dendronised polymers (10a–d and 12a–d) are compared. (c) Representative fluorescence microscopy images of transfection efficiencies in MCF-7 cells with fluorinated dendronised polymers 11c and 12c at N/P = 2.5 and 5 compared to Lipofectamine 2000. (d) MCF-7 cells were transfected with a large EGFP-expressing plasmid (10.3 kb); transfection efficiency was quantified with flow cytometry. Polymer 12c achieved a significantly higher transfection efficiency than Lipofectamine 2000 (p ≤ 0.0001). (e) Delivery of large EGFP plasmid to MCF-7 cells using fluorinated dendronised polymer 12c compared to Lipofectamine 2000. (f) Reaction scheme for fluorination of terminal PAMAM primary amines using heptafluorobutyric anhydride. Dendronised polymers 9a–10d were all treated to give fluorinated dendronised polymers 11a–12d using the same method.
Fig. 3Cotransfection experiments in HEK293T, HeLa and MCF-7 cell lines. (a and b) Cell lines were cotransfected with two pDNAs of equal size encoding EGFP and mCherry (both 5.3 kb). (c and d) Cell lines were cotransfected with plasmids of different size encoding EGFP (10.3 kb) and mCherry (5.3 kb). Cotransfection efficiency was measured using flow cytometry (a and c), and visualised using epifluorescence microscopy (b and d) where concurrent expression of both plasmids appears yellow. The fluorinated dendronised polymer 12c formulation demonstrated significantly higher cotransfection levels of multiple-sized plasmids compared to Lipofectamine 2000 across all tested cell lines (p ≤ 0.0001).
Fig. 4Transfection of MCF-7 cells with CRISPR/dCas9, TALEs and ZFs using VP64 effector for the activation of MASPIN. Transfection using polymer 12c resulted in increased MASPIN mRNA (a) across all platforms and increased MASPIN protein (b) levels for CRISPR/dCas9 compared to Lipofectamine 2000 (**p ≤ 0.01, ***p ≤ 0.001, ****p ≤ 0.0001, ns p > 0.05). Cells were transfected with an empty plasmid as a control.